Oncology Pharma inks license agreement for mrna intellectual property
Apr. 07, 2021 3:40 PM ETOncology Pharma Inc. (ONPH)By: Aakash Babu, SA News Editor
Oncology Pharma (OTCPK:ONPH +10.0%) has signed a license agreement with Regen BioPharma for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer. The license agreement expands the company's portfolio of intellectual property that it plans to develop for niche biotechnology markets.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.